With the U.S. clinical trial of an innovative lung cancer drug developed in Cuba showing positive preliminary results, Buffalo-based Roswell Park Comprehensive Cancer Center and Havana’s Center for Molecular Immunology have embarked on a biotech joint venture designed to bring four promising Cuban cancer drugs to U.S. patients.


Recent Articles

Date Title
10/19/18 Trump takes aim at Cuba, holds Havana responsible for Venezuelan crisis
Franco Ordóñez, McClatchy DC Bureau
10/15/18 Cuba’s Miguel Díaz-Canel is the latest world leader to open Twitter account
Mimi Whitefield, Miami Herald
10/4/18 Cuba’s handpicked president displayed multiple faces during visit to the United Nations
Nora Gámez Torres, Miami Herald
10/4/18 Current Record